Does Patent Strategy Shape the Long-Run Supply of Public Knowledge?
暂无分享,去创建一个
[1] William Shockley,et al. The theory of p-n junctions in semiconductors and p-n junction transistors , 1949, Bell Syst. Tech. J..
[2] R. Nelson. The Simple Economics of Basic Scientific Research , 1959, Journal of Political Economy.
[3] D J PRICE,et al. NETWORKS OF SCIENTIFIC PAPERS. , 1965, Science.
[4] W. Hagstrom. The scientific community , 1966 .
[5] Martin L. Weitzman,et al. Free Access vs. Private Ownership as Alternative Systems for Managing Common Property , 1974 .
[6] N. Rosenberg. Science, Invention and Economic Growth , 1974 .
[7] George J. Stigler,et al. The Citation Practices of Doctorates in Economics , 1975, Journal of Political Economy.
[8] J. Hausman. Specification tests in econometrics , 1978 .
[9] James Austin. Laboratory life: The social construction of scientific facts: by Bruno Latour and Steve Woolgar. Sage, Beverly Hills, CA, 1979. , 1982 .
[10] Z. Griliches,et al. Econometric Models for Count Data with an Application to the Patents-R&D Relationship , 1984 .
[11] A. Cameron,et al. Econometric models based on count data. Comparisons and applications of some estimators and tests , 1986 .
[12] M. Ferber,et al. CITATIONS AND NETWORKING , 1988 .
[13] Daniel A. Levinthal,et al. ABSORPTIVE CAPACITY: A NEW PERSPECTIVE ON LEARNING AND INNOVATION , 1990 .
[14] U.S. seeks patent on genetic codes, setting off furor. , 1991, The New York times on the Web.
[15] S. Scotchmer,et al. Standing on the Shoulders of Giants: Cumulative Research and the Patent Law , 1991 .
[16] B. Kogut,et al. Knowledge of the Firm, Combinative Capabilities, and the Replication of Technology , 1992 .
[17] P. David,et al. Toward a new economics of science , 1994 .
[18] I. Cockburn,et al. Measuring competence?: exploring firm effects in pharmaceutical research , 1994 .
[19] M. Brewer,et al. Intellectual Capital and the Birth of U.S. Biotechnology Enterprises , 1994 .
[20] J. Lerner. The Importance of Patent Scope: An Empirical Analysis , 1994 .
[21] Paul M. Romer,et al. The Origins of Endogenous Growth , 1994 .
[22] R. Kohler,. Lords of the fly: Drosophila genetics and the experimental life. , 1995 .
[23] D. Yao,et al. Some Reflections on the Antitrust Treatment of Intellectual Property , 1995 .
[24] Richard R. Nelson,et al. On the Sources and Significance of Interindustry Differences in Technological Opportunities , 1995 .
[25] W. Powell,et al. Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .
[26] Rebecca S. Eisenberg,et al. Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research , 1996 .
[27] M. Trajtenberg,et al. University Versus Corporate Patents: A Window On The Basicness Of Invention , 1997 .
[28] Kimberly S. Hamilton,et al. The increasing linkage between U.S. technology and public science , 1997 .
[29] Melissa S. Anderson,et al. Withholding research results in academic life science. Evidence from a national survey of faculty. , 1997, JAMA.
[30] Pravin K. Trivedi,et al. Regression Analysis of Count Data , 1998 .
[31] D. Resnik. Conflicts of Interest in Science , 1998, Perspectives on Science.
[32] D. Resnik. Industry‐Sponsored Research: Secrecy versus Corporate Responsibility , 1998 .
[33] J. Gans,et al. Incumbency and R&D Incentives: Licensing the Gale of Creative Destruction , 1999 .
[34] Pravin K. Trivedi,et al. Regression Analysis of Count Data , 1998 .
[35] R. Nelson,et al. Economic Theories about the Benefits and Costs of Patents , 1998 .
[36] M. Heller,et al. Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.
[37] J. Merz,et al. Disease gene patents: overcoming unethical constraints on clinical laboratory medicine. , 1999, Clinical chemistry.
[38] B. Kogut,et al. Localization of Knowledge and the Mobility of Engineers in Regional Networks , 1999 .
[39] Morten T. Hansen,et al. The Search-Transfer Problem: The Role of Weak Ties in Sharing Knowledge across Organization Subunits , 1999 .
[40] Carl Shapiro,et al. Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting , 2000, Innovation Policy and the Economy.
[41] M. Meyer. Does science push technology? Patents citing scientific literature , 2000 .
[42] Richard A. Posner,et al. An Economic Analysis of the Use of Citations in the Law , 2000 .
[43] Philippe Ducor,et al. Coauthorship and Coinventorship , 2000, Science.
[44] M A Holman,et al. Intellectual property rights in genes and gene fragments: a registration solution for expressed sequence tags. , 2000, Iowa law review.
[45] O. Sorenson,et al. Science as a Map in Technological Search , 2000 .
[46] E. Duflo,et al. How Much Should We Trust Differences-in-Differences Estimates? , 2001 .
[47] D. Harhoff,et al. Determinants of Opposition against EPO Patent Grants – The Case of Biotechnology and Pharmaceuticals ∗ , 2002 .
[48] S. Hilgartner,et al. Data withholding in academic genetics: evidence from a national survey. , 2002, JAMA.
[49] Jon F. Merz,et al. DNA Patenting and Licensing , 2002, Science.
[50] Jerry G. Thursby,et al. Special Issue on University Entrepreneurship and Technology Transfer: Who Is Selling the Ivory Tower? Sources of Growth in University Licensing , 2002, Manag. Sci..
[51] R. Tijssen. Science dependence of technologies: evidence from inventions and their inventors , 2002 .
[52] J. Gans,et al. The Product Market and the Market for 'Ideas': Commercialization Strategies for Technology Entrepreneurs , 2002 .
[53] Fiona E. Murray. Innovation as co-evolution of scientific and technological networks: exploring tissue engineering , 2002 .
[54] Mildred K Cho,et al. Effects of patents and licenses on the provision of clinical genetic testing services. , 2003, The Journal of molecular diagnostics : JMD.
[55] W. Powell,et al. The expanding role of university patenting in the life sciences: assessing the importance of experience and connectivity , 2003 .
[56] Deepak Somaya. Strategic determinants of decisions not to settle patent litigation , 2003 .
[57] I. Cockburn,et al. Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery , 2003 .
[58] Michelle Gittelman,et al. Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns , 2003, Manag. Sci..
[59] Lori Rosenkopf,et al. Startup size and the mechanisms of external learning: increasing opportunity and decreasing ability? , 2003 .
[60] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[61] Lawrence Lessig,et al. Free Culture: How Big Media Uses Technology and the Law to Lock Down Culture and Control Creativity , 2004 .
[62] Rosemarie H. Ziedonis. Don't Fence Me in: Fragmented Markets for Technology and the Patent Acquisition Strategies of Firms , 2003, Manag. Sci..
[63] Marc Rysman,et al. Patents and the Performance of Voluntary Standard Setting Organizations , 2005 .
[64] Wesley M. Cohen,et al. View from the Bench: Patents and Material Transfers , 2005, Science.
[65] Michael A. Hitt,et al. Management Theory and Research: Potential Contribution to Public Policy and Public Organizations , 2005 .
[66] Fiona Murray,et al. Intellectual Property Landscape of the Human Genome , 2005, Science.
[67] Benjamin Coriat,et al. Are “strong patents” beneficial to innovative activities? Lessons from the genetic testing for breast cancer controversies , 2005 .
[68] G. Hoetker,et al. DEATH HURTS, BUT IT ISN'T FATAL: THE POSTEXIT DIFFUSION OF KNOWLEDGE CREATED BY INNOVATIVE COMPANIES. , 2005 .
[69] E. Hippel,et al. Free revealing and the private-collective model for innovation incentives , 2006 .
[70] M. Angrist,et al. Who owns the genome? , 2006, New Atlantis.
[71] E. Garfield. Citation indexes for science. A new dimension in documentation through association of ideas. 1955. , 1955, International journal of epidemiology.
[72] Debra L. Greenfield. Greenberg v. Miami Children 's Hospital: unjust enrichment and the patenting of human genetic material. , 2006, Annals of health law.
[73] Fiona E. Murray. The stem-cell market - patents and the pursuit of scientific progress. , 2007, The New England journal of medicine.
[74] Fiona Murray,et al. Exploring the Foundations of Cumulative Innovation: Implications for Organization Science , 2007, Organ. Sci..
[75] Eric von Hippel,et al. Norms-Based Intellectual Property Systems: The Case of French Chefs , 2006, Organ. Sci..
[76] Michael A. Heller,et al. The Gridlock Economy: How Too Much Ownership Wrecks Markets, Stops Innovation, and Costs Lives , 2008 .
[77] Scott Stern,et al. Climbing Atop the Shoulders of Giants: The Impact of Institutions on Cumulative Research , 2006, American Economic Review.
[78] Fiona E. Murray,et al. Entrepreneurial Experiments in Science Policy: Analyzing the Human Genome Project , 2009 .
[79] K. Huang,et al. Mobility, retention and productivity of genomics scientists in the United States , 2014, Nature Biotechnology.
[80] K. Huang. Uncertain Intellectual Property Conditions and Knowledge Appropriation Strategies: Evidence from the Genomics Industry , 2017 .